Isoprenoids and Alzheimer's disease: A complex relationship

Cholesterol metabolism has been linked to Alzheimer's disease (AD) neuropathology, which is characterized by amyloid plaques, neurofibrillary tangles and neuroinflammation. Indeed, the use of statins, which inhibit cholesterol and isoprenoid biosynthesis, as potential AD therapeutics is under i...

Full description

Bibliographic Details
Main Authors: S.L. Cole, R. Vassar
Format: Article
Language:English
Published: Elsevier 2006-05-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996105003098
_version_ 1818616220835905536
author S.L. Cole
R. Vassar
author_facet S.L. Cole
R. Vassar
author_sort S.L. Cole
collection DOAJ
description Cholesterol metabolism has been linked to Alzheimer's disease (AD) neuropathology, which is characterized by amyloid plaques, neurofibrillary tangles and neuroinflammation. Indeed, the use of statins, which inhibit cholesterol and isoprenoid biosynthesis, as potential AD therapeutics is under investigation. Whether statins offer benefit for AD will be determined by the outcome of large, placebo-controlled, randomized clinical trials. However, their use as pharmacological tools has delineated novel roles for isoprenoids in AD. Protein isoprenylation regulates multiple cellular and molecular events and here we review the complex roles of isoprenoids in AD-relevant processes and carefully evaluate isoprenoid pathways as potential AD therapeutic targets.
first_indexed 2024-12-16T16:46:21Z
format Article
id doaj.art-cc87c6a30ec2493e940d6c4a06d7c394
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-16T16:46:21Z
publishDate 2006-05-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-cc87c6a30ec2493e940d6c4a06d7c3942022-12-21T22:24:11ZengElsevierNeurobiology of Disease1095-953X2006-05-01222209222Isoprenoids and Alzheimer's disease: A complex relationshipS.L. Cole0R. Vassar1Corresponding author. Fax: +1 312 503 7912.; Department of Cell and Molecular Biology, Northwestern University Medical School, Chicago, IL 60611, USADepartment of Cell and Molecular Biology, Northwestern University Medical School, Chicago, IL 60611, USACholesterol metabolism has been linked to Alzheimer's disease (AD) neuropathology, which is characterized by amyloid plaques, neurofibrillary tangles and neuroinflammation. Indeed, the use of statins, which inhibit cholesterol and isoprenoid biosynthesis, as potential AD therapeutics is under investigation. Whether statins offer benefit for AD will be determined by the outcome of large, placebo-controlled, randomized clinical trials. However, their use as pharmacological tools has delineated novel roles for isoprenoids in AD. Protein isoprenylation regulates multiple cellular and molecular events and here we review the complex roles of isoprenoids in AD-relevant processes and carefully evaluate isoprenoid pathways as potential AD therapeutic targets.http://www.sciencedirect.com/science/article/pii/S0969996105003098Alzheimer's diseaseStatinsIsoprenoidsCholesterolAPP metabolismAβ
spellingShingle S.L. Cole
R. Vassar
Isoprenoids and Alzheimer's disease: A complex relationship
Neurobiology of Disease
Alzheimer's disease
Statins
Isoprenoids
Cholesterol
APP metabolism

title Isoprenoids and Alzheimer's disease: A complex relationship
title_full Isoprenoids and Alzheimer's disease: A complex relationship
title_fullStr Isoprenoids and Alzheimer's disease: A complex relationship
title_full_unstemmed Isoprenoids and Alzheimer's disease: A complex relationship
title_short Isoprenoids and Alzheimer's disease: A complex relationship
title_sort isoprenoids and alzheimer s disease a complex relationship
topic Alzheimer's disease
Statins
Isoprenoids
Cholesterol
APP metabolism

url http://www.sciencedirect.com/science/article/pii/S0969996105003098
work_keys_str_mv AT slcole isoprenoidsandalzheimersdiseaseacomplexrelationship
AT rvassar isoprenoidsandalzheimersdiseaseacomplexrelationship